SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-21-029931
Filing Date
2021-05-28
Accepted
2021-05-28 16:21:11
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea141837-s3_adialpharma.htm S-3 304933
2 OPINION OF GRACIN & MARLOW, LLP ea141837ex5-1_adialpharma.htm EX-5.1 7652
3 CONSENT OF FRIEDMAN LLP ea141837ex23-1_adialpharma.htm EX-23.1 2071
4 GRAPHIC image_001.jpg GRAPHIC 27640
5 GRAPHIC ex5-1_001.jpg GRAPHIC 4732
  Complete submission text file 0001213900-21-029931.txt   360741
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-256621 | Film No.: 21980508
SIC: 2834 Pharmaceutical Preparations